{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:35Z","timestamp":1786987535461,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.critrevonc.2025.104792","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:48:30Z","timestamp":1749160110000},"page":"104792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring the role of TERT in thyroid Cancer: A systematic review"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-4653","authenticated-orcid":false,"given":"Thais","family":"Maloberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana Jessica","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calafato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Coluccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Colapinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Colombero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Credi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Nannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"de Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104792_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/1440-1681.13223","article-title":"Role of telomerase in the tumour microenvironment","volume":"47","author":"Liu","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051147","article-title":"TERT promoter alterations in glioblastoma: a systematic review","volume":"13","author":"Olympios","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104792_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14080800","article-title":"Molecular characterization of Advanced-Stage melanomas in clinical practice using a Laboratory-Developed Next-Generation sequencing panel","volume":"14","author":"Maloberti","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2025.104792_bib4","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v28.i25.2854","article-title":"Correlation of molecular alterations with pathological features in hepatocellular carcinoma: literature review and experience of an Italian center","volume":"28","author":"Maloberti","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-regulation and roles in cancer formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib6","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104792_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2020.02.001","article-title":"TERT promoter mutations and telomeres during tumorigenesis","volume":"60","author":"Lorbeer","year":"2020","journal-title":"Curr. Opin. Genet Dev."},{"key":"10.1016\/j.critrevonc.2025.104792_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jmoldx.2020.11.003","article-title":"A pan-cancer study of somatic TERT promoter mutations and amplification in 30,773 tumors profiled by clinical genomic sequencing","volume":"23","author":"Gupta","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2025.104792_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2025.104792_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jclinpath-2018-205653","article-title":"Gene: its function and dysregulation in cancer","volume":"72","author":"Colebatch","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.2013.0045","article-title":"The increasing incidence of thyroid cancer: the influence of access to care","volume":"23","author":"Morris","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib12","unstructured":"Society, A.C. 2024. Key Statistics for Thyroid Cancer. \u3008https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/about\/key-statistics.html\u3009."},{"key":"10.1016\/j.critrevonc.2025.104792_bib13","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.29251","article-title":"Thyroid cancer mortality and incidence: a global overview","volume":"136","author":"La Vecchia","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","article-title":"Thyroid cancer incidence trends by histology in 25 countries: a population-based study","volume":"9","author":"Miranda-Filho","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044057","article-title":"Expanding the spectrum of BRAF Non-V600E mutations in thyroid nodules: evidence-based data from a tertiary referral centre","volume":"24","author":"De Leo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104792_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102039","article-title":"Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer","volume":"8","author":"Nannini","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2025.104792_bib18","article-title":"Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: an individual patient data meta-analysis","volume":"240","author":"Vuong","year":"2022","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.critrevonc.2025.104792_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","article-title":"Poorly differentiated thyroid carcinoma: the turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach","volume":"31","author":"Volante","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106904","article-title":"Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: a systematic review and meta-analysis","volume":"196","author":"Chen","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.critrevonc.2025.104792_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-020-01202-5","article-title":"Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101357","article-title":"Prevalence of restless legs syndrome in people with diabetes mellitus: a pooling analysis of observational studies","volume":"46","author":"Ning","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.critrevonc.2025.104792_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10040250","article-title":"Molecular diagnostic of solid tumor using a next generation sequencing Custom-Designed Multi-Gene panel","volume":"10","author":"de Biase","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.critrevonc.2025.104792_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1060504","article-title":"Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis","volume":"14","author":"Anaclerio","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2025.104792_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137154","article-title":"Multi-Gene testing overview with a clinical perspective in metastatic Triple-Negative breast cancer","volume":"22","author":"Dameri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104792_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jclinpath-2021-207429","article-title":"Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel","volume":"75","author":"Sgariglia","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib28","first-page":"285","article-title":"Next-generation sequencing in clinical practice: is it a Cost-Saving alternative to a Single-Gene testing approach?","volume":"5","author":"Pruneri","year":"2021","journal-title":"Pharm. Open"},{"key":"10.1016\/j.critrevonc.2025.104792_bib29","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease","volume":"98","author":"Landa","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104792_bib31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/ERC-14-0359","article-title":"Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib32","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/cncr.28800","article-title":"TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA","volume":"120","author":"Wang","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib33","doi-asserted-by":"crossref","first-page":"E1571","DOI":"10.1210\/jc.2014-1158","article-title":"Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma","volume":"99","author":"Wang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib34","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/onc.2013.446","article-title":"The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas","volume":"33","author":"Liu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104792_bib35","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib36","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integration gemonic characterization of papillary thyroid carcinoma","volume":"159","author":"network","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104792_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1530\/ERC-15-0396","article-title":"TERT promoter mutations in thyroid cancer: a report from a middle eastern population","volume":"22","author":"Qasem","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jc.2014-1634","article-title":"Clinical and molecular features of hurthle cell carcinoma of the thyroid","volume":"100","author":"Chindris","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib40","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.1210\/jc.2014-3606","article-title":"Association of TERT promoter mutation 1,295,228C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer","volume":"100","author":"Shi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.mce.2014.10.019","article-title":"Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization","volume":"399","author":"Muzza","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2015.0101","article-title":"TERT promoter mutations in papillary thyroid microcarcinomas","volume":"25","author":"de Biase","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/EJE-14-0837","article-title":"TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma","volume":"172","author":"Gandolfi","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib44","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2025.104792_bib45","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.29934","article-title":"Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients","volume":"122","author":"Song","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib46","article-title":"BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104792_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-16-0219","article-title":"TERT promoter mutations and long-term survival in patients with thyroid cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jamaoncol.2016.3288","article-title":"Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in thyroid cancer mortality","volume":"3","author":"Liu","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/srep41752","article-title":"TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors","volume":"7","author":"Matsuse","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104792_bib50","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1210\/jc.2016-2785","article-title":"TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease","volume":"102","author":"Melo","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2016.0254","article-title":"Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases","volume":"27","author":"Bonhomme","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib52","doi-asserted-by":"crossref","first-page":"42613","DOI":"10.18632\/oncotarget.17300","article-title":"NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma","volume":"8","author":"Tiedje","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104792_bib53","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1089\/thy.2016.0645","article-title":"TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance","volume":"27","author":"Yabuta","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.5005","article-title":"Genetic landscape of papillary thyroid carcinoma in the Chinese population","volume":"244","author":"Liang","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2017.12.027","article-title":"Predictive factors of outcome in poorly differentiated thyroid carcinomas","volume":"92","author":"de la Fouchardiere","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1530\/ERC-18-0050","article-title":"TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours","volume":"25","author":"Paulsson","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104792_bib57","first-page":"9174","article-title":"Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: a single institute experience","volume":"15","author":"Romei","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104792_bib58","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1210\/en.2019-00315","article-title":"Impact of BRAF V600E and TERT promoter mutations on response to therapy in papillary thyroid cancer","volume":"160","author":"Trybek","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.critrevonc.2025.104792_bib59","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1002\/cam4.2467","article-title":"Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer","volume":"8","author":"Panebianco","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2025.104792_bib60","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1210\/jc.2019-00431","article-title":"Genomic and transcriptomic characterization of papillary microcarcinomas with lateral neck lymph node metastases","volume":"104","author":"Perera","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib61","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/iub.2056","article-title":"TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower (131) I uptake in metastases","volume":"71","author":"Meng","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.critrevonc.2025.104792_bib62","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/thy.2020.0086","article-title":"Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases","volume":"30","author":"Xu","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051345","article-title":"Genomic and transcriptomic characteristics according to size of papillary thyroid microcarcinoma","volume":"12","author":"Song","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104792_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082115","article-title":"TERT promoter mutation and extent of thyroidectomy in patients with 1\u20134\u2009cm intrathyroidal papillary carcinoma","volume":"12","author":"Ebina","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104792_bib65","article-title":"Prospective analysis of TERT promoter mutations in papillary thyroid carcinoma at a single institution","volume":"10","author":"Choi","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.critrevonc.2025.104792_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.surg.2021.03.056","article-title":"Presence of TERT +\/- BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma","volume":"170","author":"Lee","year":"2021","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2025.104792_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.808298","article-title":"TERT promoter mutations are an independent predictor of distant metastasis in middle eastern papillary thyroid microcarcinoma","volume":"13","author":"Parvathareddy","year":"2022","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib68","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3803\/EnM.2022.1477","article-title":"Frequency of TERT promoter mutations in Real-World analysis of 2,092 thyroid carcinoma patients","volume":"37","author":"Yang","year":"2022","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104792_bib69","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1007\/s00259-022-05820-x","article-title":"The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer","volume":"49","author":"Cao","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2025.104792_bib70","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1089\/thy.2022.0155","article-title":"A significance of concomitant BRAF(V600E) and TERT mutations in polish patients with papillary thyroid microcarcinoma: a retrospective cohort study based on 430 cases","volume":"32","author":"Kuchareczko","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","article-title":"Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations","volume":"35","author":"Park","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1156999","article-title":"Mutational profiling of Chinese patients with thyroid cancer","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib73","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.23500","article-title":"Facilitation of definitive cancer diagnosis with quantitative molecular assays of BRAF V600E and TERT promoter variants in patients with thyroid nodules","volume":"6","author":"Fu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2025.104792_bib74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1369\/00221554231190437","article-title":"5hmC immunohistochemistry: a predictor of TERT promoter mutational status in follicular thyroid carcinoma?","volume":"71","author":"Hysek","year":"2023","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.critrevonc.2025.104792_bib75","article-title":"Clinicopathological and genetic characteristics of patients of different ages with diffuse sclerosing variant papillary thyroid carcinoma","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104792_bib76","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","article-title":"Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104792_bib77","article-title":"Role of ultrasound in predicting telomerase reverse transcriptase (TERT) promoter mutation in follicular thyroid carcinoma","volume":"14","author":"Kim","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104792_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75087-9","article-title":"TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer","volume":"14","author":"Tan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104792_bib79","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/thy.2018.0695","article-title":"TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas","volume":"29","author":"Tanaka","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.critrevonc.2025.104792_bib80","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.aab0015","article-title":"Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer","volume":"348","author":"Bell","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2025.104792_bib81","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/his.15157","article-title":"Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients","volume":"84","author":"Ghossein","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2025.104792_bib82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/EJE-16-0863","article-title":"Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis","volume":"176","author":"Vuong","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104792_bib83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-024-03738-3","article-title":"Correction to: molecular pathology of endocrine gland tumors: genetic alterations and clinicopathologic relevance","volume":"484","author":"De Leo","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2025.104792_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-015-0089-7","article-title":"Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells","volume":"13","author":"Selvaraj","year":"2015","journal-title":"Cell Commun. Signal"}],"updated-by":[{"DOI":"10.1016\/j.critrevonc.2025.104863","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000}}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T20:46:58Z","timestamp":1756154818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":84,"alternative-id":["S1040842825001805"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104792","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the role of TERT in thyroid Cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104792"}}